JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cohen, J.
Right arrow Articles by Neff, N. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cohen, J.
Right arrow Articles by Neff, N. H.

Neuroleptic drugs activate tyrosine hydroxylase of retinal amacrine cells

J Cohen, PM Iuvone and NH Neff

Tyrosine hydroxylase of retinal dopamine-containing amacrine cells exists in two states, a basal state in the dark and an activated state in the light. Treatment with haloperidol, chlorpromazine, clozapine or domperidone results in activation of tyrosine hydroxylase in the dark. With haloperidol, the magnitude of the activation was dose-related. After a single dose of haloperidol (3 mg/kg i.p.) enzyme activation persisted for at least 3 hr. By kinetic analysis, activation was characterized as a decrease in the Km for the pteridine cofactor. Activation by light induces similar kinetic changes. Apparently, the dopaminergic system of retina responds to neuroleptic drug treatment similar to that nigrostriatal dopaminergic system.

Volume 218, Issue 2, pp. 390-394, 08/01/1981
Copyright © 1981 by American Society for Pharmacology and Experimental Therapeutics






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics.